CMS will no longer tolerate Medicare Part D gag clauses
As part of a larger federal effort, the Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma issued a
Read More
Part D/Prescription Drugs
ALS patients losing time and hope as they wait for insurers to cover a pricey new drug
(By Ed Silverman for ST A T) For the past two years, Sarah Benoit has been getting around with the
Read MoreNew Type Of Drug To Prevent Migraines Heads To Market
(By Richard Harris for NPR) The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines
Read MoreRight-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says
(By Ike Swetlitz and Erin Mershon for ST A T) WHITE OAK, Md. — The House is set to take
Read MoreVermont Legislators Pass A Drug Importation Law. So What?
(By Shefali Luthra for Kaiser Health News) This week, Vermont passed a first-in-the-nation law that would facilitate the state’s importation
Read MoreFDA calls out 39 drug companies for allegedly blocking access to generics
(By Erin Mershon for ST A T) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially
Read MoreHow A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read MoreCMS is initiating a National Coverage Analysis for CAR-T therapies
In 2017, the Food and Drug Administration approved the first chimeric antigen receptor (CAR)-T cell therapies, now the Centers for
Read MoreIn a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal
(By Lev Facher for ST A T) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first
Read MoreChanges to Medicare Part D for 2019
When the President signed the Bipartisan Budget Act of 2018 on February 9 th , this legislation affected those individuals
Read More